Susquehanna Fundamental Investments’s Meridian Bioscience Inc VIVO Stock Holding History

Susquehanna Fundamental Investments’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-30,259	Closed	-$533K	–	426
2019 Q1	$533K	Sell	30,259 -34,100	-53%	-$567K	0.06%	273
2018 Q4	$1.12M	Sell	64,359 -6,354	-9%	-$108K	0.2%	145
2018 Q3	$1.05M	Sell	70,713 -18,246	-21%	-$283K	0.18%	166
2018 Q2	$1.41M	Buy	88,959 +24,159	+37%	+$360K	0.21%	151
2018 Q1	$920K	Buy	+64,800	New	+$959K	0.11%	268

Other funds holding VIVO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna Fundamental Investments's VIVO Position: Q2 2019 in Review

Susquehanna Fundamental Investments sold out of Meridian Bioscience Inc (VIVO) in Q2 2019, closing a stake of 30,259 shares — an estimated $533K sold.

Susquehanna Fundamental Investments first reported a position in VIVO in Q1 2018 and held it in 5 quarters. The position peaked at $1.41M in Q2 2018. 173 funds tracked by Wall St. Rank hold VIVO as of Q2 2019.

Susquehanna Fundamental Investments reported no remaining Meridian Bioscience Inc position as of Q2 2019 after selling out during the quarter.
Susquehanna Fundamental Investments sold 30,259 Meridian Bioscience Inc shares in Q2 2019, an estimated $533K.
Susquehanna Fundamental Investments first reported a position in Meridian Bioscience Inc in Q1 2018 and held it in 5 quarters.
Susquehanna Fundamental Investments's Meridian Bioscience Inc position peaked at $1.41M in Q2 2018.
173 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2019.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2019, filed 14 Aug 2019.